AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation

NCT01001091 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

312

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: AL-38583 ophthalmic solution
DRUG: AL-38583 ophthalmic solution vehicle
DRUG: Dexamethasone ophthalmic suspension, 0.1%

Sponsor

Alcon Research

Collaborators

[object Object]